Skip to main content
TipRanks
Go Ultimate75% OFF

Rod Martin Insider Profile

4 Followers

Rod Martin, Director at Galectin Therapeutics, holds 2.98M shares in Galectin Therapeutics (Ticker: GALT).

Rod Martin's Trading History

GALT
Galectin Therapeutics
Jul 08, 2015DirectorUninformative Buy―$9.35M
GALT
Insider Shares: 2.98M (12.45%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 08, 2015Uninformative Buy$0.0028,179$0.00―
May 15, 2014Informative Buy$150.00K83,334$1.80-76.50%
Jan 28, 2014Informative Buy$1.50M500,000$3.00-73.10%
Jan 14, 2014Informative Sell$1.48M100,000$14.84-3.80%
Nov 05, 2013Informative Buy$300.00K100,000$3.00―

You May Also Like

Rod Martin insider profile FAQ

What is the percentage of profitable transactions made by Rod Martin?
The percentage of profitable transactions made by Rod Martin is 0%.
What is the average return per transaction made by Rod Martin?
The average return per transaction made by Rod Martin is -51.10%.
What stocks does Rod Martin hold?
Rod Martin holds: GALT stocks.
What was Rod Martin's most profitable transaction?
Rod Martin’s most profitable transaction was an Informative Sell of GALT stock on January 14, 2014. The return on the trade was -3.80%.
What is Rod Martin's role in Galectin Therapeutics?
Rod Martin's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.